VYG-EFV-100

VYG-EFV-100 is a diagnostic contrast agent developed by Voyageur Pharmaceuticals for use in radiology and CT imaging procedures. It is part of a suite of imaging products designed to enhance visualization during diagnostic scans. While specific chemical details are limited in public pipeline disclosures, it is categorized alongside effervescent and barium/iodine-based agents. As a contrast medium, it functions by altering the absorption of X-rays in the body, thereby providing radiopacity and improving the clarity of internal structures in medical imaging. The 'EFV' designation likely refers to an effervescent formulation, which is typically used to distend the gastrointestinal tract for better visualization during imaging.